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ABSTRACT 
 
“To study the role of diffusion weighted MRI in predicting response to concurrent 
chemoradiotherapy or radical radiotherapy in locally advanced laryngeal and 
hypopharyngeal malignancy as part of the organ preservation protocol.” 
 
Introduction: According to the Globocan fact sheet, worldwide there are approximately     
1,30,000 new laryngeal cases and a reported of 70,000 deaths annually. Hypopharyngeal cases 
are less common with approximately one-fourth of as many cases. According to the Indian 
data there are about 20000 cases being reported for laryngeal malignancy and about 37,000 
cases of hypopharyngeal malignancy. Laryngeal and hypopharyngeal malignanacy were  
Traditionally treated with surgery  which severely affected the quality of life of patients  
(impaired swallowing and eating and speech deficit) as well as social losses due to cosmetic 
deformity from surgery. Organ-preserving approach with concurrent chemoradiotherapy or 
radical radiotherapy followed by salvage surgery in case of residual or relapse, has now been 
accepted as a standard management for locally advanced laryngeal and hypopharyngeal 
malignancy. However, not all patients respond to the treatment & end up undergoing surgery. 
However if the outcome can be predicted before or at an early stage of treatment using imaging 
biomarkers like diffusion weighted MRI(dWMRI). The treatment outcome may be improved 
by using an optimized treatment strategy tailored for individual patient. 
 
Objective: To study the role of diffusion weighted MRI derived parameters like ADC as an 
imaging biomarker to predict response to concurrent chemoradiotherapy or radical 
radiotherapy in locally advanced squamous cell carcinoma larynx and hypopharynx. The 
secondary outcome was to validate the role of diffusion weighted MRI to detect, characterize 
and monitor the response to chemoradiotherapy or radical radiotherapy. 
 
Methodology: Our study group consisted of 19 patients with male predilection and 
predominantly T3 stage treated with organ preservation intent with concurrent 
chemoradiotherapy or radical radiotherapy were assessed for treatment response with dWMRI 
at baseline, first week, fourth week and at follow up. The ADC values were compared at 
different timepoints and correlated with treatment response. 
 
Results: The potential of using dWMRI in predicting early treatment response in patients 
with locally advanced laryngeal and hypopharyngeal malignancy being treated with organ 
preservation approach. The pretreatment ADC values were correlated with treatment 
response. Based on the results of this study pretereatment ADC could predict treatment 
response with a sensitivity of 80% and specificity of 62%. It was observed that an abrupt rise 
from the pretreatment ADC to the first week ADC was characteristic of complete response 
while a gradual rise of ADC over the different points suggested a partial treatment response. 
We were also able to correlate between ADC values at different time points and also between 
pretreatment ADC and pretreatment size. However these observations have to be validated 
over larger study population to derive meaningful outcome.  
 
Conclusion: It was feasible to use dWMRI as an imaging biomarker to predict treatment 
response. The dWMRI with the ADC values allowed early response prediction which 
correlated with tumour response. The rate of increase in the ADC value is independent of the 
pretreatment ADC and is more important to predict response.The slow rise or no change in 
the ADC values may predict partial or no response. Thus early treatment response prediction 
would help in offering individualised treatment to our patient population by administering 
early surgical interventions in case of non responders or offer dose escalation / boost 
radiotherapy in case of partial treatment response. 
 
 
